Wilhelm-Klein-Strasse 27
Basel, 4025
Switzerland
lung cancer; neoadjuvant; chemotherapy; immunotherapy; durvalumab; stage IIIA
tumor-associated NK cells, human lung cancer, single-nucleus RNA and ATAC sequencing
Resectable non-small cell lung cancer, FDG-PET/CT, surveillance, Recurrence, Second curatively intended treatment